These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 12510953)

  • 1. From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma.
    Campbell LM
    Int J Clin Pract; 2002 Dec; 56(10):783-90. PubMed ID: 12510953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State of the art in beta2-agonist therapy: a safety review of long-acting agents.
    Rabe KF
    Int J Clin Pract; 2003 Oct; 57(8):689-97. PubMed ID: 14627180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting beta 2-agonists. Role in primary care asthma treatment.
    D'Urzo AD
    Can Fam Physician; 1997 Oct; 43():1773-7. PubMed ID: 9356758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.
    Naedele-Risha R; Dorinsky P; Craig TJ
    J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of salmeterol and formoterol in attenuating airway responses to short-acting beta2-agonists.
    van Veen A; Weller FR; Wierenga EA; Jansen HM; Jonkers RE
    Pulm Pharmacol Ther; 2003; 16(3):153-61. PubMed ID: 12749831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different bronchodilating effect of salmeterol and formoterol in an adult asthmatic.
    Ulrik CS; Kok-Jensen A
    Eur Respir J; 1994 May; 7(5):1003-5. PubMed ID: 7914175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature.
    Bisgaard H
    Pediatr Pulmonol; 2000 Mar; 29(3):221-34. PubMed ID: 10686044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long and short of beta2-agonists.
    Lötvall J
    Pulm Pharmacol Ther; 2002; 15(6):497-501. PubMed ID: 12493336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-acting beta-2-agonists in the treatment of asthma].
    Rochat T
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1714-9. PubMed ID: 7939538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma.
    Welsh EJ; Cates CJ
    Cochrane Database Syst Rev; 2010 Sep; 2010(9):CD008418. PubMed ID: 20824877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients.
    Grembiale RD; Pelaia G; Naty S; Vatrella A; Tranfa CM; Marsico SA
    Pulm Pharmacol Ther; 2002; 15(5):463-6. PubMed ID: 12406669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [symbol: see text] Seretide and [symbol: see text] Symbicort in asthma management.
    Drug Ther Bull; 2002 Aug; 40(8):62-4. PubMed ID: 12216339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?
    Lipworth BJ
    Drug Saf; 1997 May; 16(5):295-308. PubMed ID: 9187530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma.
    Bartow RA; Brogden RN
    Drugs; 1998 Feb; 55(2):303-22. PubMed ID: 9506248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting inhaled beta2-agonists in asthma therapy.
    Moore RH; Khan A; Dickey BF
    Chest; 1998 Apr; 113(4):1095-108. PubMed ID: 9554653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy in asthma--fixed or variable dosing in different patients?
    Lötvall J
    Curr Med Res Opin; 2004 Nov; 20(11):1711-27. PubMed ID: 15537472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.